Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 14, 2017

M&As this week: Pragmin Prognosis, Forefront Medical Technology

Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.

Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.

Forefront Medical Technology Pte Ltd plans to acquire Seychelles-based medical device contract manufacturer Chelle Medical Limited from a group of investors for S$6.8m ($5m).

"The acquisition will enable the Singapore-based company to expand its medical devices products portfolio."

The acquisition will enable the Singapore-based company to expand its medical devices products portfolio.

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU